Acurx Pharmaceuticals Llc Stock Current Valuation
| ACXP Stock | USD 1.25 0.10 8.70% |
Valuation analysis of Acurx Pharmaceuticals LLC helps investors to measure Acurx Pharmaceuticals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of 12/01/2024, Enterprise Value is likely to grow to about 56.6 M, while Enterprise Value Over EBITDA is likely to drop (2.65). Fundamental drivers impacting Acurx Pharmaceuticals' valuation include:
Price Book 7.9263 | Enterprise Value 15.4 M | Enterprise Value Ebitda (3.54) |
Undervalued
Today
Please note that Acurx Pharmaceuticals' price fluctuation is relatively risky at this time. Calculation of the real value of Acurx Pharmaceuticals LLC is based on 3 months time horizon. Increasing Acurx Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Acurx Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 1.25, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.25 | Real 3.99 | Target 12.33 | Hype 1.26 | Naive 0.99 |
The intrinsic value of Acurx Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Acurx Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Acurx Pharmaceuticals LLC helps investors to forecast how Acurx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Acurx Pharmaceuticals more accurately as focusing exclusively on Acurx Pharmaceuticals' fundamentals will not take into account other important factors: Acurx Pharmaceuticals LLC Company Current Valuation Analysis
Acurx Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Acurx Pharmaceuticals Current Valuation | 15.35 M |
Most of Acurx Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acurx Pharmaceuticals LLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Acurx Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Acurx Pharmaceuticals is extremely important. It helps to project a fair market value of Acurx Stock properly, considering its historical fundamentals such as Current Valuation. Since Acurx Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Acurx Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Acurx Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Acurx Current Valuation Historical Pattern
Today, most investors in Acurx Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Acurx Pharmaceuticals' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Acurx Pharmaceuticals current valuation as a starting point in their analysis.
Acurx Pharmaceuticals Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Acurx Pharmaceuticals LLC has a Current Valuation of 15.35 M. This is 99.89% lower than that of the Biotechnology sector and 99.67% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.91% higher than that of the company.
Acurx Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Acurx Pharmaceuticals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Acurx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Acurx Pharmaceuticals by comparing valuation metrics of similar companies.Acurx Pharmaceuticals is currently under evaluation in current valuation category among its peers.
Acurx Fundamentals
| Return On Equity | -3.47 | ||||
| Return On Asset | -1.32 | ||||
| Current Valuation | 15.35 M | ||||
| Shares Outstanding | 16.89 M | ||||
| Shares Owned By Insiders | 14.80 % | ||||
| Shares Owned By Institutions | 11.96 % | ||||
| Number Of Shares Shorted | 443.72 K | ||||
| Price To Book | 7.93 X | ||||
| EBITDA | (14.58 M) | ||||
| Net Income | (14.58 M) | ||||
| Cash And Equivalents | 9.09 M | ||||
| Cash Per Share | 0.80 X | ||||
| Total Debt | 3.04 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 19.43 X | ||||
| Book Value Per Share | 0.32 X | ||||
| Cash Flow From Operations | (9.8 M) | ||||
| Short Ratio | 12.59 X | ||||
| Earnings Per Share | (1.09) X | ||||
| Target Price | 11.19 | ||||
| Beta | -1.72 | ||||
| Market Capitalization | 21.12 M | ||||
| Total Asset | 7.71 M | ||||
| Retained Earnings | (53.22 M) | ||||
| Working Capital | 4.67 M | ||||
| Net Asset | 7.71 M |
About Acurx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Acurx Pharmaceuticals LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acurx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acurx Pharmaceuticals LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Acurx Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acurx Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Acurx Stock
| 0.73 | VTRS | Viatris | PairCorr |
| 0.72 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.72 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.59 | GILD | Gilead Sciences | PairCorr |
| 0.5 | WAT | Waters | PairCorr |
The ability to find closely correlated positions to Acurx Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acurx Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acurx Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acurx Pharmaceuticals LLC to buy it.
The correlation of Acurx Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acurx Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acurx Pharmaceuticals LLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acurx Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.